Clinical Trial Update: Efficacy and Safety of Berberine in the Treatment of Diabetes With Dyslipidemia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating berberine for type 2 diabetes with dyslipidemia/metabolic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Type 2 Diabetes Mellitus

Drugs mentioned

• Berberine (berberine)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Diabetes Mellitus, Type 2, Metabolic Syndrome | Phase 3 | Status: COMPLETED